Access to Subspecialty Hepatology Care Increases Survival Among V.A. Patients With Liver Disease
Access to subspecialty GI care may be difficult for patients with liver disease, but it is unknown whether access influences outcomes. A total of 28,861 patients within the Veterans Administration were studied to determine rates and predictors of access to ambulatory GI subspecialty care for patients with liver disease, and to determine whether this
Can Blood Levels of Ammonia Predict Risk and Frequency of Hepatic Encephalopathy in Patients With Cirrhosis?
We have long argued about the benefits of ammonia levels in following patients with cirrhosis and altered mentation. The textbook answer, long “re-posted”, is that the levels are not useful. But, whenever we follow recommendations historically and by habit–without thinking about the underlying rationale–we are at risk of getting burned. So it may be with
Failed Hepatitis C therapy increases risk for hepatocellular carcinoma
Patients with hepatitis C virus infection who failed interferon-free therapy have an increased risk for a specific type of carcinoma of the liver compared with patients who achieved sustained virologic response, according to recently published data.
Dr. Manoj Mehta is moving!
- For Medical Professionals
- General GI
- GERD
- Inflammatory Bowel Disease
- Irritable Bowel Syndrome
- Liver Disease
- Uncategorized
Dr. Manoj Mehta is proud to announce his move to a new, modern facility in downtown Wilmette! After 15 years practicing in nearby Kenilworth, we’re moving to a 2400 square foot facility with a spacious waiting room, comfortable surroundings, and an in-office endoscopy suite with full-time anesthesia. As always, you can expect the same level
